Usa city Boston county Rock virus covid-19 RNA pandemic Usa city Boston county Rock

Atea closes $215m Series D round to support Covid-19 trials

Reading now: 516
www.pharmaceutical-technology.com

Boston-based Atea Pharmaceuticals has raised $215m in a Series D financing round. The investment was led by Bain Capital Life Sciences; other new investors that participated in the round include Omega Funds, Rock Springs Capital and Redmile Group.

Some of Atea’s existing investors also participated, including Ally Bridge Group and Morningside Ventures. This funding will primarily be used to support Atea’s efforts against Covid-19.

The company recently received clearance from the US Food and Drug Administration (FDA) to advance its novel antiviral drug AT-527 into a Phase II clinical trial.

This study will evaluate the safety, tolerability and efficacy of AT-527 in those aged between 45 to 80 with moderate Covid-19 and risk factors for poor

Read more on pharmaceutical-technology.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA